Cresset BioMolecular Discovery is a small English software and services company founded in 2001 that focuses on in silico drug discovery. [1]
| Founded | Letchworth, England, 2001 [1] |
|---|---|
| Founder | Andy Vinter [1] |
| Headquarters | Welwyn Garden City, England |
Number of locations | 1 (2005) |
Area served | Beatrice Leigh (CEO) Andy Vinter (CSO) |
| Products | FieldscreenTM FieldTemplaterTM [2] |
Number of employees | 7 (2005) [1] |
| Website | cresset-bind.com |
History
Andy Vinter founded Cresset in 2001 with money from the Wellcome Trust, [2] specifically from the Catalyst BioMedica Ltd subsidiary of the Trust, which has since been integrated into the general technology transfer funding activities of the Trust. [3]
Business model
Cresset revenues derive from two activities, software sales and collaborative research services. The flagship product was FieldScreen, launched in December 2004, which was followed by FieldTemplater in November 2005. In each case, research services provided proof-of-principle and field-testing of computational tools leading to productization and establishment of a secondary sales-based revenue stream. Based on news reports, Cresset has two major research partnerships, one with Pharmagene announced in March 2005 and a second with Bayer announced in January 2006.
References
- ^
a
b
c
d Sue Pearson (2005-03-15). "In Silico Drug Discovery Using Molecular Fields". Corporate Profile. Genetic Engineering News. p. 14.
Cresset BioMolecular Discovery is a drug discovery technology company that offers in silico applications for the analysis of molecular fields to identify leads and hits from compound libraries. The firm provides its technology to pharma and biotech companies as both project based services and a software product called Fieldscreen.
{{ cite news}}:|access-date=requires|url=( help);|format=requires|url=( help) - ^ a b "Translation Awards: Products". Funded Activities. Wellcome Trust. Retrieved 7 February 2008.
- ^ "Translation changes: Catalyst BioMedica Ltd activities to be integrated". Knowledge centre. Wellcome Trust. 2003-01-05. Retrieved 7 February 2008.